Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo

Published:2021-06 Issue:6 Volume:14 Page:101074
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Liang Si-yuan,Zhao Tong-chao,Zhou Zhi-hang,Ju Wu-tong,Liu Ying,Tan Yi-ran,Zhu Dong-wang,Zhang Zhi-yuan,Zhong Lai-ping

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019

2. Oral cavity carcinoma: current management, controversies, and future directions;Chinn;J. Clin. Oncol.,2015

3. Doxorubicin: nanotechnological overviews from bench to bedside;Cagel;Drug Discov. Today,2017

4. Bleomycins: towards better therapeutics;Chen;Nat. Rev. Cancer,2005

5. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy;Eloy;Eur. J. Pharm. Biopharm.,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection;Infection and Drug Resistance;2024-08

2. Efficacy and safety of carrimycin in ten patients with severe pneumonia following solid organ transplantation;World Journal of Clinical Cases;2024-05-26

3. An Acid-Responsive Iron-Based Nanocomposite for OSCC Treatment;Journal of Dental Research;2024-04-29

4. Carrimycin ameliorates lipopolysaccharide and cecal ligation and puncture-induced sepsis in mice;Chinese Journal of Natural Medicines;2024-03

5. Carrimycin in the treatment of acute promyelocytic leukemia combined with pulmonary tuberculosis: A case report;World Journal of Clinical Cases;2024-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3